Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

A phase I dose escalation study of BIBW 2992, an irreversible dual EGFR/HER2 receptor tyrosine kinase inhibitor, in patients with advanced solid tumours

Lookup NU author(s): Professor Ruth PlummerORCiD, Rebecca Perrett, Professor Hilary Calvert

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Shaw H, Plummer ER, Vidal L, Perrett RH, Pilkington M, Temple G, Fong P, Amelsberg A, Calvert AH, de Bono J

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 42nd Annual Meeting of the American Society of Clinical Oncology

Year of Conference: 2006

Pages: 127S

ISSN: 0732-183X

Publisher: Journal of Clinical Oncology, American Society of Clinical Oncology

Notes:

Library holdings: Search Newcastle University Library for this item

ISBN: 15277755

Share